Using data from a variety of sources, research published in Health Affairs gives another perspective on physician practices and attitudes.
Read More
Bivarus, which uses patient-generated data to help providers identify improvement areas, has garnered $2 million in new capital.
http://medcitynews.com/2016/03/bivarus-patient-centered-analytics/?utm_source=MedCity+News+Subscribers&utm_campaign=0d4d864c31-MCN+Daily+Email&utm_medium=email&utm_term=0_5092836c41-0d4d864c31-408793005Who would have guessed, apparently doctors who get more goodies from drug companies tend to prescribe more brand-name drugs.
Read More
JD Power releases its tenth annual survey of consumer satisfaction with health plans, finding a slight increase in satisfaction in 2016 over 2015.
Read More
Maxwell is getting smart; Maxwell Health that is, as the vendor of software relating to employer health plans raises $22 million in new capital.
http://medcitynews.com/2016/03/maxwell-health-series-c/?utm_source=MedCity+News+Subscribers&utm_campaign=96663e17c0-MCN+Daily+Email&utm_medium=email&utm_term=0_5092836c41-96663e17c0-408793005Medicare Advantage plans have lower rates of hospitalization than does the fee-for-service Medicare program, likely suggesting inefficiency in the FFS branch.
Read More
As the year starts, the Altarum Institute's Briefs relating to health spending reveal steady and moderate health spending growth.
Read More
Piecing together fragments of information, we have learned that Pieces Technology has pieced together $21.6 million in fresh investment in piecemeal fashion to further its clinical decision support software business. Now don't go to pieces.
http://medcitynews.com/2016/03/clinical-decision-support-startup/?utm_source=MedCity+News+Subscribers&utm_campaign=80ae43ce5c-MCN+Daily+Email&utm_medium=email&utm_term=0_5092836c41-80ae43ce5c-408793005&rf=1A continuation of the review of the Express Scripts 2015 Drug Trend Report, with a focus on Medicare, Medicaid and exchange business.
Read More
Express Scripts' 2015 Drug Trend Report reveals continued spending pressure from the drug category, especially branded medications, with more to come in future years.
Read More